Mikkel Noerholm

Title: Mikkel Noerholm: Innovator in Microvesicle Isolation Technologies

Introduction

Mikkel Noerholm is a prominent inventor based in Gauting, Germany. He has made significant contributions to the field of microvesicle isolation, holding a total of 10 patents. His work focuses on developing innovative methods and compositions that enhance the accuracy and reliability of biological sample analysis.

Latest Patents

Mikkel Noerholm's latest patents include groundbreaking technologies such as "Compositions and methods for internal controls of microvesicle isolations." This patent provides compositions, methods, and kits that utilize enveloped viruses, including inactive mouse hepatitis virus (MHV), as internal controls for microvesicle isolations. Another notable patent is "Controls for nucleic acid assays," which features a method and kit for isolating microvesicles or extracting microvesicle nucleic acids from biological samples using control particles. These control particles, which can be viruses or virus-like particles, contain control nucleic acids that are detectable, allowing for the assessment of the accuracy and efficiency of the isolation or extraction processes. The methods also include the analysis of biomarkers associated with diseases for diagnostic and monitoring purposes.

Career Highlights

Throughout his career, Mikkel Noerholm has worked with notable companies such as Exosome Diagnostics, Inc. and The General Hospital Corporation. His expertise in microvesicle technology has positioned him as a leader in the field, contributing to advancements that have significant implications for medical diagnostics and research.

Collaborations

Mikkel has collaborated with esteemed colleagues, including Johan Karl Olov Skog and Daniel Enderle, further enhancing the impact of his work in the scientific community.

Conclusion

Mikkel Noerholm's innovative contributions to microvesicle isolation technologies have established him as a key figure in the field. His patents and collaborations reflect a commitment to advancing medical diagnostics and improving the reliability of biological sample analysis.